Gloria Matthews
Director/Board Member bei Orthopaedic Research Society
Profil
Gloria Matthews is currently the Treasurer & Director at Orthopaedic Research Society.
Previously, she worked as the Senior Director & Global Head at Genzyme Corp.
from 2009 to 2015.
She also served as an Independent Director at Bone Therapeutics SA. From 2015 to 2017, she was the Chief Medical Officer at Histogenics Corp.
and from 2017 to 2019, she worked as the Senior Vice President-Research & Development at MiMedx Group, Inc. Dr. Matthews received her undergraduate and doctorate degrees from Cornell University.
Aktive Positionen von Gloria Matthews
| Unternehmen | Position | Beginn |
|---|---|---|
| Orthopaedic Research Society | Director/Board Member | - |
Ehemalige bekannte Positionen von Gloria Matthews
| Unternehmen | Position | Ende |
|---|---|---|
| MIMEDX GROUP, INC. | Chief Tech/Sci/R&D Officer | 01.01.2019 |
| OCUGEN, INC. | Chief Tech/Sci/R&D Officer | 29.09.2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | 01.06.2015 |
| BIOSENIC SA | Director/Board Member | - |
Ausbildung von Gloria Matthews
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MIMEDX GROUP, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
| Orthopaedic Research Society |
